MiNK Therapeutics Inc. Made Big Gain

Tue, Apr 12, 2022 at 05:30 PM
MiNK Therapeutics Inc. Made Big Gain

MiNK Therapeutics Inc. (INKT:NASDAQ) shot up at $3.18, a gain of 28.7%. The stock appeared on our News Catalysts scanner on Fri, Mar 18, 2022 at 10:04 AM in the 'INVESTOR UPDATE' category. From Tue, Mar 29, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days

About MiNK Therapeutics Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.